Format

Send to

Choose Destination
J Mol Med (Berl). 2010 Feb;88(2):143-7. doi: 10.1007/s00109-009-0574-9.

Genome-based approaches to vaccine development.

Author information

1
Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy. john.telford@novartis.com

Abstract

The hundreds of bacterial genome sequences available together with advances in bioinformatics and the development of new experimental proteomic tools are revolutionizing the vaccinology field. The merge of stringent in silico criteria and different experimental approaches is allowing a more targeted strategy to obtain a restricted and prioritized list of potential antigens for testing in immunogenicity assays, reducing the time and the cost of novel protein vaccine formulations.

PMID:
20066390
DOI:
10.1007/s00109-009-0574-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center